Inventor · disambiguated record
Carl-Johan Dalsgaard
Also filed as: DALSGAARD CARL-JOHAN
6 granted patents·15 pending applications·13 citations·filing 2008–2024
77Inventor score
Top patents by PatentIndex Score
21 records- 0193US11819494B2Treatment of idiopathic pulmonary fibrosisVICORE PHARMA AB·Filed 2022·Granted Nov 21, 2023·5 cites·19 claims
- 0293US11123329B1Use of angiotensin II type 2 receptor agonistVICORE PHARMA AB·Filed 2020·Granted Sep 21, 2021·5 cites·14 claims
- 0390US12128029B2Treatment of idiopathic pulmonary fibrosisVICORE PHARMA AB·Filed 2023·Granted Oct 29, 2024·1 cites·25 claims
- 0484US12213961B2Treatment of idiopathic pulmonary fibrosisVICORE PHARMA AB·Filed 2023·Granted Feb 4, 2025·0 cites·27 claims
- 0583US2025177355A1Treatment of idiopathic pulmonary fibrosisVICORE PHARMA AB·Filed 2024·Application pending·0 cites
- 0666US9492454B2Use of pemirolast in the treatment of acute asthmaRSPR PHARMA AB·Filed 2016·Granted Nov 15, 2016·1 cites·8 claims
- 0765US9415051B1Use of pemirolastRSPR PHARMA AB·Filed 2015·Granted Aug 16, 2016·1 cites·7 claims
- 0862US2021386712A1New use of angiotensin ii type 2 receptor agonistVICORE PHARMA AB·Filed 2021·Application pending·0 cites
- 0960US2024207230A1Method of treating a patient diagnosed with an interstitial lung diseaseVICORE PHARMA AB·Filed 2023·Application pending·0 cites
- 1058US2024207232A1Method of treating a patient diagnosed with an interstitial lung diseaseVICORE PHARMA AB·Filed 2023·Application pending·0 cites
- 1156US2024207231A1Method of treating a patient diagnosed with an interstitial lung diseaseVICORE PHARMA AB·Filed 2023·Application pending·0 cites
- 1254US2022233480A1Use of angiotensin ii type 2 receptor agonistVICORE PHARMA AB·Filed 2022·Application pending·0 cites
- 1347US2021401807A1New composition comprising amorphous nanoporous silica particlesVICORE PHARMA AB·Filed 2019·Application pending·0 cites
- 1446US2011092463A1Combination for use in the treatment of inflammatory disordersRAUD JOHAN·Filed 2009·Application pending·0 cites
- 1544US2010184783A1Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonistRAUD JOHAN·Filed 2008·Application pending·0 cites
- 1643US2021236425A1New treatment of interstitial lung diseasesINIM PHARMA AB·Filed 2019·Application pending·0 cites
- 1742US2017112838A1Use of pemirolastRSPR PHARMA AB·Filed 2016·Application pending·0 cites
- 1840US2016243122A1Use of pemirolast in the treatment of acute asthmaRSPR PHARMA AB·Filed 2015·Application pending·0 cites
- 1932US2012329813A1Pemirolast for the Treatment of Systemic Low Grade InflammationRAUD JOHAN·Filed 2010·Application pending·0 cites
- 2031US2016310493A1Use of pemirolast in the treatment of acute asthmaRSPR PHARMA AB·Filed 2016·Application pending·0 cites
- 2131US2017112837A1Use of pemirolastRSPR PHARMA AB·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carl-Johan Dalsgaard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →